The Pharmacy and Therapeutics (P&T) Committee is responsible for developing and maintaining medications and related products listed on the Ohio Department of Medicaid’s (ODM) Unified Preferred Drug List (UPDL) pursuant to the Ohio Revised Code § 5164.7510. The UPDL is maintained through a review of current evidence-based medicine and based upon the professional judgment of physicians, pharmacists, and other experts that participate in ODM’s Pharmacy and Therapeutics (P&T) Committee. The UPDL list can be found under the Drug Coverage tab.
The P&T Committee is composed of ten members appointed by the Medicaid Director. The P&T Committee members meet up to four times per year-including an annual review of the entire UPDL. Topics that may be discussed at meetings include:
- New brand or generic drugs
- UPDL changes based on any local or national issues (including contract issues)
- Stakeholder feedback through a Public Comment session
The members of the P&T Committee are:
- Scott Baran, RPh; Ohio Department of Medicaid
- Mary Ann Dzurec, PharmD; Liaison, Ohio Pharmacists Association
- Suzanne Eastman, RPh, MS, Vice Chair; Liaison, Ohio Pharmacists Association
- Stephen Hersey, MD; Liaison, American Academy of Pediatrics
- Karen Jacobs, DO, Chair; Specialty Psychiatry; Liaison, Ohio Psychiatric Physicians Association
- Melissa Jefferis, MD; Specialty Family Medicine; Liaison, Ohio Academy of Family Physicians
- Sherri Sievers, APRN; Liaison, Ohio Association of Advanced Practice Nurses
Meeting Schedule and Minutes
| Year | 2022 |
|---|---|
| Quarter 1 | Quarter 2 |
|
Meeting Date: January 12, 2022 Location: TBA Agenda: Currently unavailable Minutes: Currently unavailable Supplemental Information: Currently unavailable |
Meeting Date: April 6, 2022 Location: TBA Agenda: Currently unavailable Minutes: Currently unavailable Supplemental Information: Currently unavailable |
| Quarter 3 | Quarter 4 |
|
Meeting Date: July 13, 2022 Location: TBA Agenda: Currently unavailable Minutes: Currently unavailable Supplemental Information: Currently unavailable |
Meeting Date: October 5, 2022 Location: TBA Agenda: Currently unavailable Minutes: Currently unavailable Supplemental Information: Currently unavailable |
| Year | 2021 |
|---|---|
| Quarter 1 | Quarter 2 |
|
Meeting Date: January 13, 2021 Location: GoToMeeting After you click the link and register, a dial in number will be provided. Agenda: DOWNLOAD Minutes: DOWNLOAD Supplemental Information: Currently unavailable |
Meeting Date: April 14, 2021 Location: GoToMeeting After you click the link and register, a dial in number will be provided. Agenda: DOWNLOAD Minutes: DOWNLOAD Supplemental Information: Currently unavailable |
| Quarter 3 | Quarter 4 |
|
Meeting Date: July 14, 2021 Location: CANCELLED Agenda: DOWNLOAD Minutes: Currently unavailable Supplemental Information: Currently unavailable |
Meeting Date: October 6, 2021 Location: GoToMeeting After you click the link and register, you will receive an email containing information about joining the webinar. Agenda: DOWNLOAD Minutes: DOWNLOAD Supplemental Information: DOWNLOAD |
Interested in Presenting?
- Interested parties are permitted to speak or provide written testimony to the Committee virtually. Presentations must be related to a meeting agenda item. To be confirmed as a presenter at the meeting, please refer to Article V – PUBLIC PARTICIPATION of the By-Laws and see the links below.
- Drug Manufacturer
- Non-Drug Manufacturer
It is the policy of the Ohio Department of Medicaid (ODM) that all ODM public meetings are accessible to people with disabilities. If you need assistance in participating in this meeting due to a disability as defined under the ADA, please call ODM’s ADA Coordinator at 614-995-9981/TTY 711, Fax 1-614-644-1434, or Email: ODM_EEO_EmployeeRelations@medicaid.ohio.gov at least three (3) business days prior to the scheduled meeting to request an accommodation. Further information can be found here: Notice of Nondiscrimination.
Have Questions? Members of the Ohio Department of Medicaid P&T Committee have requested that all clinical information, questions or comments about the preferred drug list (UPDL) be sent directly to Change Healthcare, the ODM FFS PBM. Manufacturers and other interested parties are requested not to contact the members directly.
Written comments on the UPDL from all interested parties should be submitted to the appropriate Change Healthcare contact. Manufacturers submitting comments are requested to do so through their product manager.
Clinical Comments:
Change Healthcare
Email: PBA_OHMedicaidFFS@changehealthcare.com
Rebate Comments or Other Financial Information:
Steve Liles, PharmD
Senior Director, Pharmacy Services
Change Healthcare
Email: sliles@changehealthcare.com
Comments about the Medicaid pharmacy program or non-UPDL issues can be addressed to:
Ohio Department of Medicaid
Pharmacy Services Unit
PO Box 182709
Columbus, OH 43218-2709
Email: medicaid_pharmacy@medicaid.ohio.gov